268 related articles for article (PubMed ID: 12373774)
41. [Changes of the activities of ET-1 in the serum and BALF of ILD patients and their clinical significance].
Li Z; Xia S; Hou X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jul; 22(7):411-3. PubMed ID: 11775813
[TBL] [Abstract][Full Text] [Related]
42. [Detection of TNF-alpha and NCF in the serum and BALF of patients with sarcoidosis and evaluate their clinical significance].
Li Z; Chen W; Hou X; Yu R
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):37-9. PubMed ID: 11812354
[TBL] [Abstract][Full Text] [Related]
43. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
44. Gastrin-releasing peptide-like immunoreactive substance in bronchoalveolar lavage of idiopathic pulmonary fibrosis and sarcoidosis.
Takeyama M; Nagai S; Kondo K; Morikawa N; Mio T; Satake N; Kitaichi M; Izumi T
Eur Respir J; 1993 Mar; 6(3):418-24. PubMed ID: 8472833
[TBL] [Abstract][Full Text] [Related]
45. Detection and identification of human bronchoalveolar lavage proteins using narrow-range immobilized pH gradient DryStrip and the paper bridge sample application method.
Sabounchi-Schütt F; Aström J; Eklund A; Grunewald J; Bjellqvist B
Electrophoresis; 2001 May; 22(9):1851-60. PubMed ID: 11425242
[TBL] [Abstract][Full Text] [Related]
46. Proteome analysis of bronchoalveolar lavage in lung diseases.
Magi B; Bargagli E; Bini L; Rottoli P
Proteomics; 2006 Dec; 6(23):6354-69. PubMed ID: 17133372
[TBL] [Abstract][Full Text] [Related]
47. Bronchoalveolar lavage fluid proteins in human lung disease: analysis by two-dimensional electrophoresis.
Lenz AG; Meyer B; Costabel U; Maier K
Electrophoresis; 1993 Mar; 14(3):242-4. PubMed ID: 8486137
[TBL] [Abstract][Full Text] [Related]
48. Induction of angiotensin converting enzyme in cultured human monocytes by a factor present in the bronchoalveolar lavage fluid of sarcoidosis patients.
Rohrbach MS; Vuk-Pavlović Z; Martin WJ; DeLaval P; Genetet N
Sarcoidosis; 1988 Mar; 5(1):17-23. PubMed ID: 2837820
[TBL] [Abstract][Full Text] [Related]
49. Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis.
Rozy A; Czerniawska J; Stepniewska A; Woźbińska B; Goljan A; Puścińska E; Górecka D; Chorostowska-Wynimko J
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():335-40. PubMed ID: 17072062
[TBL] [Abstract][Full Text] [Related]
50. Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis.
Shirahama R; Miyazaki Y; Okamoto T; Inase N; Yoshizawa Y
Allergol Int; 2010 Dec; 59(4):409-15. PubMed ID: 20962569
[TBL] [Abstract][Full Text] [Related]
51. [Concentration of thromboxane B2 in bronchoalveolar lavage fluid in selected interstitial pulmonary diseases].
Zielonka TM; Rybus L; Doboszyńska A; Wałajtys-Rode E; Walkiewicz R; Droszcz W
Przegl Lek; 1995; 52(6):315-7. PubMed ID: 7568987
[TBL] [Abstract][Full Text] [Related]
52. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
53. Protein C anticoagulant system in patients with interstitial lung disease.
Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
[TBL] [Abstract][Full Text] [Related]
54. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
[TBL] [Abstract][Full Text] [Related]
55. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model.
Wong WS; Zhao J
Int Arch Allergy Immunol; 2008; 147(3):179-89. PubMed ID: 18594147
[TBL] [Abstract][Full Text] [Related]
56. Asbestos bodies in bronchoalveolar lavage fluid. A study of 20 asbestos-exposed individuals and comparison to patients with other chronic interstitial lung diseases.
Roggli VL; Piantadosi CA; Bell DY
Acta Cytol; 1986; 30(5):470-6. PubMed ID: 3465136
[TBL] [Abstract][Full Text] [Related]
57. [Determination of elastase and alpha 2-macroglobulin in bronchoalveolar lavage fluid in patients with interstitial diseases and its clinical significance].
Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Dec; 14(6):333-5, 375-6. PubMed ID: 1726366
[TBL] [Abstract][Full Text] [Related]
58. Oxidized BAL fluid proteins in patients with interstitial lung diseases.
Lenz AG; Costabel U; Maier KL
Eur Respir J; 1996 Feb; 9(2):307-12. PubMed ID: 8777969
[TBL] [Abstract][Full Text] [Related]
59. [Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis].
Li JZ; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):378-80. PubMed ID: 15256084
[TBL] [Abstract][Full Text] [Related]
60. A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.
Landi C; Bargagli E; Carleo A; Bianchi L; Gagliardi A; Prasse A; Perari MG; Refini RM; Bini L; Rottoli P
Proteomics Clin Appl; 2014 Dec; 8(11-12):932-50. PubMed ID: 25169739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
